The Europe Sexually Transmitted Diseases (STD) Testing Market would witness market growth of 4.0% CAGR during the forecast period (2021-2027).
The growth of the sexually transmitted diseases (STD) testing market are increased public awareness and patient education. Furthermore, rising number of education programmes, and an increase in government initiatives would fuel the demand for STD testing. In the last decade, the frequency and incidence of STDs have increased dramatically. Several countries around the world are highly focusing on implementing nationwide screening programmes to boost STD diagnosis coverage. Additionally, reimbursement policies for STD services have been beneficial for patients, which is further contributing considerably to the growth of STD testing market.
HIV/AIDS prevention, treatment, and care are gaining more significance in Europe over the last few decades. In the WHO European Region, where no country has been spared, more than two million individuals are infected with the disease. Despite the fact that this number is low when compared to the worst-affected region, it marks an unprecedented spike in new cases. The rapid spread of HIV in Eastern Europe, in particular, is one of the region's most pressing public health issues. In addition, Europe is likely to provide the most instructive combination of both actual success stories (from the region's western and central parts) and cautionary tales of missed possibilities (from its eastern part).
The Germany market dominated the Europe Sexually Transmitted Diseases (STD) Testing Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $8.07 billion by 2027. The UK market is estimated to witness a CAGR of 3.3% during (2021 - 2027). Additionally, The France market would experience a CAGR of 4.8% during (2021 - 2027).
Based on Disease Type, the market is segmented into Chlamydia, Herpes simplex, Gonorrhea, Syphilis, Human papillomavirus (HPV), and Other Disease. Based on the Location of Testing, the market is segmented into Laboratory Testing and Point of care (POC) Testing. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Sexually Transmitted Diseases (STD) Testing Market Size will Hit $120 Billion by 2027, at a CAGR of 4.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMérieux S.A., Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin Molecular LLC, Danaher Corporation, Bio-Rad Laboratories, Inc., and OraSure Technologies, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Disease Type
- Chlamydia
- Herpes simplex
- Gonorrhea
- Syphilis
- Human papillomavirus (HPV)
- Other Disease
By Location of Testing
- Laboratory Testing
- Point of care (POC) Testing
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- BioMérieux S.A.
- Abbott Laboratories
- Becton, Dickinson and Company
- Hologic, Inc.
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd.
- DiaSorin Molecular LLC
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- OraSure Technologies, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Sexually Transmitted Diseases (STD) Testing Market, by Disease Type
1.4.2 Europe Sexually Transmitted Diseases (STD) Testing Market, by Location of Testing
1.4.3 Europe Sexually Transmitted Diseases (STD) Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Oct – 2021, Dec) Leading Players
Chapter 4. Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type
4.1 Europe Chlamydia Market by Country
4.2 Europe Herpes simplex virus Market by Country
4.3 Europe Gonorrhea Market by Country
4.4 Europe Syphilis Market by Country
4.5 Europe Human papillomavirus (HPV) Market by Country
4.6 Europe Other Disease Market by Country
Chapter 5. Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
5.1 Europe Laboratory Testing Market by Country
5.2 Europe Point of care (POC) Testing Market by Country
Chapter 6. Europe Sexually Transmitted Diseases (STD) Testing Market by Country
6.1 Germany Sexually Transmitted Diseases (STD) Testing Market
6.1.1 Germany Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.1.2 Germany Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2 UK Sexually Transmitted Diseases (STD) Testing Market
6.2.1 UK Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.2 UK Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3 France Sexually Transmitted Diseases (STD) Testing Market
6.3.1 France Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.2 France Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4 Russia Sexually Transmitted Diseases (STD) Testing Market
6.4.1 Russia Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.2 Russia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.5 Spain Sexually Transmitted Diseases (STD) Testing Market
6.5.1 Spain Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.5.2 Spain Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.6 Italy Sexually Transmitted Diseases (STD) Testing Market
6.6.1 Italy Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.6.2 Italy Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.7 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market
6.7.1 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.7.2 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
Chapter 7. Company Profiles
7.1 BioMérieux S.A.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Research & Development Expenses
7.2 Abbott Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trials:
7.3 Becton, Dickinson and Company
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Hologic, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Approvals and Trials:
7.4.5.2 Product Launches and Product Expansions:
7.4.5.3 Acquisition and Mergers:
7.5 Thermo Fisher Scientific, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.6 SWOT Analysis
7.6 F. Hoffmann-La Roche Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Product Launches and Product Expansions:
7.7 DiaSorin Molecular LLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Danaher Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Bio-Rad laboratories, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.10. OraSure Technologies, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional & Segmental Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Product Launches and Product Expansions:
7.10.5.2 Acquisition and Mergers:
TABLE 1 Europe Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 2 Europe Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Sexually Transmitted Diseases (STD) Testing Market
TABLE 4 Product Launches And Product Expansions– Sexually Transmitted Diseases (STD) Testing Market
TABLE 5 Acquisition and Mergers– Sexually Transmitted Diseases (STD) Testing Market
TABLE 6 approvals and trials– Sexually Transmitted Diseases (STD) Testing Market
TABLE 7 Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 8 Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 9 Europe Chlamydia Market by Country, 2017 - 2020, USD Million
TABLE 10 Europe Chlamydia Market by Country, 2021 - 2027, USD Million
TABLE 11 Europe Herpes simplex virus Market by Country, 2017 - 2020, USD Million
TABLE 12 Europe Herpes simplex virus Market by Country, 2021 - 2027, USD Million
TABLE 13 Europe Gonorrhea Market by Country, 2017 - 2020, USD Million
TABLE 14 Europe Gonorrhea Market by Country, 2021 - 2027, USD Million
TABLE 15 Europe Syphilis Market by Country, 2017 - 2020, USD Million
TABLE 16 Europe Syphilis Market by Country, 2021 - 2027, USD Million
TABLE 17 Europe Human papillomavirus (HPV) Market by Country, 2017 - 2020, USD Million
TABLE 18 Europe Human papillomavirus (HPV) Market by Country, 2021 - 2027, USD Million
TABLE 19 Europe Other Disease Market by Country, 2017 - 2020, USD Million
TABLE 20 Europe Other Disease Market by Country, 2021 - 2027, USD Million
TABLE 21 Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 22 Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 23 Europe Laboratory Testing Market by Country, 2017 - 2020, USD Million
TABLE 24 Europe Laboratory Testing Market by Country, 2021 - 2027, USD Million
TABLE 25 Europe Point of care (POC) Testing Market by Country, 2017 - 2020, USD Million
TABLE 26 Europe Point of care (POC) Testing Market by Country, 2021 - 2027, USD Million
TABLE 27 Europe Sexually Transmitted Diseases (STD) Testing Market by Country, 2017 - 2020, USD Million
TABLE 28 Europe Sexually Transmitted Diseases (STD) Testing Market by Country, 2021 - 2027, USD Million
TABLE 29 Germany Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 30 Germany Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 31 Germany Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 32 Germany Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 33 Germany Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 34 Germany Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 35 UK Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 36 UK Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 37 UK Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 38 UK Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 39 UK Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 40 UK Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 41 France Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 42 France Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 43 France Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 44 France Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 45 France Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 46 France Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 47 Russia Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 48 Russia Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 49 Russia Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 50 Russia Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 51 Russia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 52 Russia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 53 Spain Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 54 Spain Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 55 Spain Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 56 Spain Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 57 Spain Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 58 Spain Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 59 Italy Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 60 Italy Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 61 Italy Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 62 Italy Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 63 Italy Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 64 Italy Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 65 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 66 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 67 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 68 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 69 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 70 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 71 Key information – BioMérieux S.A.
TABLE 72 Key Information – Abbott Laboratories
TABLE 73 Key information – Becton, Dickinson and Company
TABLE 74 Key information – Hologic, Inc.
TABLE 75 Key Information – Thermo Fisher Scientific, Inc.
TABLE 76 key information – F. Hoffmann-La Roche Ltd.
TABLE 77 Key information – DiaSorin Molecular LLC
TABLE 78 Key Information – Danaher Corporation
TABLE 79 Key Information – Bio-Rad Laboratories, Inc.
TABLE 80 Key information – OraSure Technologies, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 1 KBV Cardinal Matrix
FIG 2 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 3 Key Strategic Move: (Product Launches and Product Expansions : 2019, Oct – 2021, dec) Leading Players
FIG 4 Recent strategies and developments: Hologic, Inc.
FIG 5 Swot analysis: thermo fisher scientific, inc.
FIG 6 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 7 Recent strategies and developments: OraSure Technologies, Inc.